Hilar cholangiocarcinoma

Victor M. Zaydfudim, Charles B. Rosen, David M. Nagorney

Research output: Contribution to journalReview article

23 Citations (Scopus)

Abstract

Optimal treatment of hilar cholangiocarcinoma depends on location of the cancer and extent of biliary and vascular involvement. Candidates for resection or transplantation must be evaluated and managed by a multidisciplinary team at a high-volume hepatobiliary center. Success requires absence of distant nodal or extrahepatic metastases and an adequate functional liver remnant with a negative ductal margin. Ipsilateral portal vein resection and reconstruction should be performed in patients with venous involvement. Neoadjuvant chemoradiation and liver transplantation is the best treatment option for patients with unresectable hilar cholangiocarcinoma without nodal or distant metastases and for patients with underlying chronic liver disease.

Original languageEnglish (US)
Pages (from-to)247-263
Number of pages17
JournalSurgical Oncology Clinics of North America
Volume23
Issue number2
DOIs
StatePublished - Apr 2014

Fingerprint

Klatskin Tumor
Neoplasm Metastasis
Portal Vein
Liver Transplantation
Blood Vessels
Liver Diseases
Chronic Disease
Transplantation
Liver
Therapeutics
Neoplasms

Keywords

  • Hepatic resection
  • Hilar cholangiocarcinoma
  • Liver transplantation
  • Vascular resection

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

Zaydfudim, V. M., Rosen, C. B., & Nagorney, D. M. (2014). Hilar cholangiocarcinoma. Surgical Oncology Clinics of North America, 23(2), 247-263. https://doi.org/10.1016/j.soc.2013.10.005

Hilar cholangiocarcinoma. / Zaydfudim, Victor M.; Rosen, Charles B.; Nagorney, David M.

In: Surgical Oncology Clinics of North America, Vol. 23, No. 2, 04.2014, p. 247-263.

Research output: Contribution to journalReview article

Zaydfudim, VM, Rosen, CB & Nagorney, DM 2014, 'Hilar cholangiocarcinoma', Surgical Oncology Clinics of North America, vol. 23, no. 2, pp. 247-263. https://doi.org/10.1016/j.soc.2013.10.005
Zaydfudim, Victor M. ; Rosen, Charles B. ; Nagorney, David M. / Hilar cholangiocarcinoma. In: Surgical Oncology Clinics of North America. 2014 ; Vol. 23, No. 2. pp. 247-263.
@article{3f9d332147a74fed87e66a2ee2167189,
title = "Hilar cholangiocarcinoma",
abstract = "Optimal treatment of hilar cholangiocarcinoma depends on location of the cancer and extent of biliary and vascular involvement. Candidates for resection or transplantation must be evaluated and managed by a multidisciplinary team at a high-volume hepatobiliary center. Success requires absence of distant nodal or extrahepatic metastases and an adequate functional liver remnant with a negative ductal margin. Ipsilateral portal vein resection and reconstruction should be performed in patients with venous involvement. Neoadjuvant chemoradiation and liver transplantation is the best treatment option for patients with unresectable hilar cholangiocarcinoma without nodal or distant metastases and for patients with underlying chronic liver disease.",
keywords = "Hepatic resection, Hilar cholangiocarcinoma, Liver transplantation, Vascular resection",
author = "Zaydfudim, {Victor M.} and Rosen, {Charles B.} and Nagorney, {David M.}",
year = "2014",
month = "4",
doi = "10.1016/j.soc.2013.10.005",
language = "English (US)",
volume = "23",
pages = "247--263",
journal = "Surgical Oncology Clinics of North America",
issn = "1055-3207",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Hilar cholangiocarcinoma

AU - Zaydfudim, Victor M.

AU - Rosen, Charles B.

AU - Nagorney, David M.

PY - 2014/4

Y1 - 2014/4

N2 - Optimal treatment of hilar cholangiocarcinoma depends on location of the cancer and extent of biliary and vascular involvement. Candidates for resection or transplantation must be evaluated and managed by a multidisciplinary team at a high-volume hepatobiliary center. Success requires absence of distant nodal or extrahepatic metastases and an adequate functional liver remnant with a negative ductal margin. Ipsilateral portal vein resection and reconstruction should be performed in patients with venous involvement. Neoadjuvant chemoradiation and liver transplantation is the best treatment option for patients with unresectable hilar cholangiocarcinoma without nodal or distant metastases and for patients with underlying chronic liver disease.

AB - Optimal treatment of hilar cholangiocarcinoma depends on location of the cancer and extent of biliary and vascular involvement. Candidates for resection or transplantation must be evaluated and managed by a multidisciplinary team at a high-volume hepatobiliary center. Success requires absence of distant nodal or extrahepatic metastases and an adequate functional liver remnant with a negative ductal margin. Ipsilateral portal vein resection and reconstruction should be performed in patients with venous involvement. Neoadjuvant chemoradiation and liver transplantation is the best treatment option for patients with unresectable hilar cholangiocarcinoma without nodal or distant metastases and for patients with underlying chronic liver disease.

KW - Hepatic resection

KW - Hilar cholangiocarcinoma

KW - Liver transplantation

KW - Vascular resection

UR - http://www.scopus.com/inward/record.url?scp=84896697203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896697203&partnerID=8YFLogxK

U2 - 10.1016/j.soc.2013.10.005

DO - 10.1016/j.soc.2013.10.005

M3 - Review article

VL - 23

SP - 247

EP - 263

JO - Surgical Oncology Clinics of North America

JF - Surgical Oncology Clinics of North America

SN - 1055-3207

IS - 2

ER -